{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T04:21:52Z","timestamp":1775881312812,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":4993,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008392","name":"Sundhed og Sygdom, Det Frie Forskningsr\u00e5d","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"publisher","award":["2000.33.1"],"award-info":[{"award-number":["2000.33.1"]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009379","name":"Interdisziplin\u00e4res Zentrum f\u00fcr Klinische Forschung, Universit\u00e4tsklinikum W\u00fcrzburg","doi-asserted-by":"publisher","award":["B-12"],"award-info":[{"award-number":["B-12"]}],"id":[{"id":"10.13039\/501100009379","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009379","name":"Interdisziplin\u00e4res Zentrum f\u00fcr Klinische Forschung, Universit\u00e4tsklinikum W\u00fcrzburg","doi-asserted-by":"publisher","award":["B-4"],"award-info":[{"award-number":["B-4"]}],"id":[{"id":"10.13039\/501100009379","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009379","name":"Interdisziplin\u00e4res Zentrum f\u00fcr Klinische Forschung, Universit\u00e4tsklinikum W\u00fcrzburg","doi-asserted-by":"publisher","award":["Wuerzburg 01 KS 9603"],"award-info":[{"award-number":["Wuerzburg 01 KS 9603"]}],"id":[{"id":"10.13039\/501100009379","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1046\/j.1523-1747.2002.01698.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T06:01:54Z","timestamp":1047448914000},"page":"595-599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Differential Expression of Inhibitory or Activating CD94\/NKG2 Subtypes on MART-1-Reactive T Cells in Vitiligo Versus Melanoma: A Case Report"],"prefix":"10.1016","volume":"118","author":[{"given":"Lars \u00d8stergaard","family":"Pedersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia S.","family":"Vetter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria C.","family":"Mingari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mads Hald","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"thor Straten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva-B","family":"Br\u00f6cker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen C.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1747.2002.01698.x_bb0010","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1126\/science.274.5284.94","article-title":"Phenotypic analysis of antigen-specific T lymphocytes","volume":"274","author":"Altman","year":"1996","journal-title":"Science"},{"key":"10.1046\/j.1523-1747.2002.01698.x_bb0015","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1046\/j.1523-1747.1999.00805.x","article-title":"Accumulation of identical T cells in melanoma and vitiligo-like leukoderma","volume":"113","author":"Becker","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2002.01698.x_bb0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/(SICI)1521-4141(199901)29:01<23::AID-IMMU23>3.0.CO;2-Y","article-title":"Transforming growth factor-beta-induced expression of CD94\/NKG2A inhibitory receptors in human T lymphocytes","volume":"29","author":"Bertone","year":"1999","journal-title":"Eur J Immunol"},{"key":"10.1046\/j.1523-1747.2002.01698.x_bb0025","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0198-8859(99)00157-3","article-title":"Early signaling via inhibitory and activating NK receptors","volume":"61","author":"Blery","year":"2000","journal-title":"Hum Immunol"},{"key":"10.1046\/j.1523-1747.2002.01698.x_bb0030","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0304-4165(94)00172-T","article-title":"Receptor-ligand interactions measured by an improved spun column chromatography technique. A high efficiency and high throughput size separation method","volume":"91","author":"Buus","year":"1995","journal-title":"Biochim Biophysica Acta"},{"key":"10.1046\/j.1523-1747.2002.01698.x_bb0035","first-page":"169","article-title":"The enigma of activating isoforms of ITIM-bearing molecules","volume":"244","author":"Cambiaggi","year":"1999","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1046\/j.1523-1747.2002.01698.x_bb0040","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/1521-4141(200001)30:1<236::AID-IMMU236>3.0.CO;2-X","article-title":"Memory CD8 T lymphocytes express inhibitory MHC-specific Ly49 receptors","volume":"30","author":"Coles","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1046\/j.1523-1747.2002.01698.x_bb0045","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/77793","article-title":"Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages","volume":"1","author":"Diefenbach","year":"2000","journal-title":"Nat Immunol"},{"key":"10.1046\/j.1523-1747.2002.01698.x_bb0050","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1615\/CritRevImmunol.v18.i1-2.90","article-title":"Tumor-specific immune response: current in vitro analyses may not reflect the in vivo immune status","volume":"18","author":"Faure","year":"1998","journal-title":"Crit Rev Immunol"},{"key":"10.1046\/j.1523-1747.2002.01698.x_bb0055","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1046\/j.1365-2249.1999.00833.x","article-title":"Expression of killer inhibitory receptors on cytotoxic cells from HIV-1-infected individuals","volume":"115","author":"Galiani","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1747.2002.01698.x_bb0060","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1074-7613(00)80426-4","article-title":"Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor","volume":"6","author":"Ikeda","year":"1997","journal-title":"Immunity"},{"key":"10.1046\/j.1523-1747.2002.01698.x_bb0065","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.immunol.16.1.359","article-title":"NK cell receptors","volume":"16","author":"Lanier","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"10.1046\/j.1523-1747.2002.01698.x_bb0070","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/83130","article-title":"On guard - activating NK cell receptors","volume":"2","author":"Lanier","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1046\/j.1523-1747.2002.01698.x_bb0075","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1074-7613(00)80441-0","article-title":"Signal transduction during natural killer cell activation. Inside the mind of a killer","volume":"6","author":"Leibson","year":"1997","journal-title":"Immunity"},{"key":"10.1046\/j.1523-1747.2002.01698.x_bb0080","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1146\/annurev.immunol.17.1.875","article-title":"Regulation of immune responses through inhibitory receptors","volume":"17","author":"Long","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"10.1046\/j.1523-1747.2002.01698.x_bb0085","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0198-8859(99)00158-5","article-title":"Expression of HLA class I-specific inhibitory receptors in human cytolytic T lymphocytes: a regulated mechanism that controls T-cell activation and function","volume":"61","author":"Mingari","year":"2000","journal-title":"Hum Immunol"},{"key":"10.1046\/j.1523-1747.2002.01698.x_bb0090","first-page":"15","article-title":"Stimulatory receptors in NK and T cells","volume":"230","author":"Moretta","year":"1998","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1046\/j.1523-1747.2002.01698.x_bb0095","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0190-9622(83)70182-9","article-title":"Vitiligo in patients with metastatic melanoma: a good prognostic sign","volume":"9","author":"Nordlund","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1523-1747.2002.01698.x_bb0100","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.188.6.1203","article-title":"High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo","volume":"188","author":"Ogg","year":"1998","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2002.01698.x_bb0105","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1002\/1521-4141(2001010)31:10<2986::AID-IMMU2986>3.0.CO;2-R","article-title":"Efficient assembly of recombinant major histocompatibility molecules with preformed disulfide bonds","volume":"31","author":"Pedersen","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1046\/j.1523-1747.2002.01698.x_bb0110","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1073\/pnas.96.10.5674","article-title":"Inhibitory receptors sensing HLA-G1 molecules in pregnancy. decidua-associated natural killer cells express LIR-1 and CD94\/NKG2A and acquire p49, an HLA-G1-specific receptor","volume":"96","author":"Ponte","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1747.2002.01698.x_bb0115","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00002371-199601000-00009","article-title":"Vitiligo in patients with melanoma: normal tissue antigens can be targets for cancer immunotherapy","volume":"19","author":"Rosenberg","year":"1996","journal-title":"J Immunother Emphasis Tumor Immunol"},{"key":"10.1046\/j.1523-1747.2002.01698.x_bb0120","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/smim.1996.0039","article-title":"Harnessing self-reactivity in cancer immunotherapy","volume":"8","author":"Schoenberger","year":"1996","journal-title":"Semin Immunol"},{"key":"10.1046\/j.1523-1747.2002.01698.x_bb0125","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(05)61810-7","article-title":"Why tyrosinase for treatment of melanoma","volume":"350","author":"Song","year":"1997","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1747.2002.01698.x_bb0130","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1084\/jem.190.6.775","article-title":"In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes","volume":"190","author":"Speiser","year":"1999","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2002.01698.x_bb0135","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1006\/clim.2000.4890","article-title":"Tumor infiltrating lymphocytes in melanoma comprise high numbers of T-cell clonotypes that are lost during in vitro culture","volume":"96","author":"thor Straten","year":"2000","journal-title":"Clin Immunol"},{"key":"10.1046\/j.1523-1747.2002.01698.x_bb0140","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1046\/j.1523-1747.2000.00958.x","article-title":"Expression of CD94\/NKG2 subtypes on tumor-infiltrating lymphocytes in primary and metastatic melanoma","volume":"114","author":"Vetter","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2002.01698.x_bb0145","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0198-8859(98)00044-5","article-title":"T cells expressing killer cell inhibitory receptors do not carry TCR for alloantigens","volume":"59","author":"Yamada","year":"1998","journal-title":"Hum Immunol"},{"key":"10.1046\/j.1523-1747.2002.01698.x_bb0150","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1084\/jem.192.11.1637","article-title":"Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of T cell-mediated vitiligo","volume":"192","author":"Yee","year":"2000","journal-title":"J Exp Med"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15416148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15416148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T18:20:41Z","timestamp":1668622841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15416148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["S0022202X15416148"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1747.2002.01698.x","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2002,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential Expression of Inhibitory or Activating CD94\/NKG2 Subtypes on MART-1-Reactive T Cells in Vitiligo Versus Melanoma: A Case Report","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1046\/j.1523-1747.2002.01698.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 The Society for Investigative Dermatology, Inc.  All rights reserved.","name":"copyright","label":"Copyright"}]}}